Atrial fibrillation: A review of modifiable risk factors and preventive strategies

1. KIRCHHOF P, BREITHARDT G, BAX J, BENNINGER G, BLOMSTROM-LUNDQVIST C, BORIANI G et al. A roadmap to improve the quality of atrial fibrillation management: Proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2016;18(1):37-50. doi:10.1093/europace/euv304.10.1093/europace/euv30426481149Open DOISearch in Google Scholar

2. HONG KL, GLOVER BM. The impact of lifestyle intervention on atrial fibrillation. Current opinion in cardiology. 2018;33(1):14-9.10.1097/HCO.000000000000047029049041Search in Google Scholar

3. RAATIKAINEN MJ, ARNAR DO, MERKELY B, CAMM AJ, HINDRICKS G. Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2016;18 Suppl 3:iii1-iii79. doi:10.1093/europace/euw244.10.1093/europace/euw24427496955Open DOISearch in Google Scholar

4. RAATIKAINEN MJP, ARNAR DO, MERKELY B, NIELSEN JC, HINDRICKS G, HEIDBUCHEL H et al. A Decade of information on the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(suppl_2):ii1-ii90. doi:10.1093/europace/eux258.10.1093/europace/eux25828903470Open DOISearch in Google Scholar

5. GARDARSDOTTIR M, SIGURDSSON S, ASPELUND T, ROKITA H, LAUNER LJ, GUDNASON V et al. Atrial fibrillation is associated with decreased total cerebral blood flow and brain perfusion. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017. doi:10.1093/europace/eux220.10.1093/europace/eux220607550929016776Open DOISearch in Google Scholar

6. FUMAGALLI S, POTPARA TS, BJERREGAARD LARSEN T, HAUGAA KH, DOBREANU D, PROCLEMER A et al. Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association survey. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(11):1896-902. doi:10.1093/europace/eux288.10.1093/europace/eux28829040554Open DOISearch in Google Scholar

7. GUERRA F, BRAMBATTI M, NIEUWLAAT R, MARCUCCI M, DUDINK E, CRIJNS H et al. Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(12):1922-9. doi:10.1093/europace/eux205.10.1093/europace/eux20529106537Open DOISearch in Google Scholar

8. BERGE T, BRYNILDSEN J, LARSSEN HKN, ONARHEIM S, JENSSEN GR, IHLE-HANSEN H et al. Systematic screening for atrial fibrillation in a 65-year-old population with risk factors for stroke: data from the Akershus Cardiac Examination 1950 study. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017(00):1-7. doi:10.1093/europace/eux293.10.1093/europace/eux29329095966Search in Google Scholar

9. CLARNETTE JA, BROOKS AG, MAHAJAN R, ELLIOTT AD, TWOMEY DJ, PATHAK RK et al. Outcomes of persistent and long-standing persistent atrial fibrillation ablation: a systematic review and meta-analysis. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2018;20(Fi_3):f366-f76. doi:10.1093/europace/eux297.10.1093/europace/eux29729267853Open DOISearch in Google Scholar

10. FIALA M, BULKOVA V, SKNOURIL L, NEVRALOVA R, TOMAN O, JANUSKA J et al. Functional improvement after successful catheter ablation for long-standing persistent atrial fibrillation. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(11):1781-9. doi:10.1093/europace/euw282.10.1093/europace/euw28227707782Search in Google Scholar

11. BELLEY-COTE EP, JAFFER I, LAMY A, WHITLOCK RP. Cost effectiveness of LAA closure in patients with AF and contraindications to warfarin: comment. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(5):882. doi:10.1093/europace/euw072.10.1093/europace/euw07227194542Open DOISearch in Google Scholar

12. MIKKELSEN AP, HANSEN ML, OLESEN JB, HVIDTFELDT MW, KARASOY D, HUSTED S et al. Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2016;18(4):492-500. doi:10.1093/europace/euv242.10.1093/europace/euv24226443443Open DOISearch in Google Scholar

13. TEUNISSEN C, KASSENBERG W, VAN DER HEIJDEN JF, HASSINK RJ, VAN DRIEL VJ, ZUITHOFF NP et al. Five-year efficacy of pulmonary vein antrum isolation as a primary ablation strategy for atrial fibrillation: a single-centre cohort study. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2016;18(9):1335-42. doi:10.1093/europace/euv439.10.1093/europace/euv43926838694Open DOISearch in Google Scholar

14. HINDRICKS G, SEPEHRI SHAMLOO A, LENARCZYK R, KALARUS Z, ARYA A, KIRCHER S et al. Catheter ablation of atrial fibrillation: current status, techniques, outcomes and challenges. Kardiologia polska. 2018. doi:10.5603/KP.a2018.0216.10.5603/KP.a2018.021630406938Open DOISearch in Google Scholar

15. SIDHU K, TANG A. Modifiable risk factors in atrial fibrillation: The role of alcohol, obesity, and sleep apnea. The Canadian journal of cardiology. 2017;33(7):947-9. doi:10.1016/j.cjca.2017.04.006.10.1016/j.cjca.2017.04.00628668145Open DOISearch in Google Scholar

16. MAIRESSE GH, MORAN P, VAN GELDER IC, ELSNER C, ROSENQVIST M, MANT J et al. Screening for atrial fibrillation: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(10):1589-623. doi:10.1093/europace/eux177.10.1093/europace/eux17729048522Search in Google Scholar

17. HOBBELT AH, SILAND JE, GEELHOED B, VAN DER HARST P, HILLEGE HL, VAN GELDER IC et al. Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(2):226-32. doi:10.1093/europace/euw016.10.1093/europace/euw016583414928175276Open DOISearch in Google Scholar

18. CALVO N, RAMOS P, MONTSERRAT S, GUASCH E, COLL-VINENT B, DOMENECH M et al. Emerging risk factors and the dose-response relationship between physical activity and lone atrial fibrillation: a prospective case-control study. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2016;18(1):57-63. doi:10.1093/europace/euv216.10.1093/europace/euv216473932326333377Open DOISearch in Google Scholar

19. PROIETTI M, RAPARELLI V, LAROCHE C, DAN GA, JANION M, POPESCU R et al. Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(9):1439-48. doi:10.1093/europace/euw169.10.1093/europace/euw16927940934Open DOISearch in Google Scholar

20. ALLAN V, HONARBAKHSH S, CASAS JP, WALLACE J, HUNTER R, SCHILLING R et al. Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants. Thrombosis and haemostasis. 2017;117(5):837-50. doi:10.1160/th16-11-0825.10.1160/th16-11-0825544260528229164Open DOISearch in Google Scholar

21. NALLIAH CJ, SANDERS P, KALMAN JM. The impact of diet and lifestyle on atrial fibrillation. Current cardiology reports. 2018;20(12):137. doi:10.1007/s11886-018-1082-8.10.1007/s11886-018-1082-830315401Open DOISearch in Google Scholar

22. WANG TJ, PARISE H, LEVY D, D'AGOSTINO RB, SR., WOLF PA, VASAN RS et al. Obesity and the risk of new-onset atrial fibrillation. Jama. 2004;292(20):2471-7. doi:10.1001/jama.292.20.2471.10.1001/jama.292.20.247115562125Open DOISearch in Google Scholar

23. HUXLEY RR, LOPEZ FL, FOLSOM AR, AGARWAL SK, LOEHR LR, SOLIMAN EZ et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011;123(14):1501-8. doi:10.1161/circulationaha.110.009035.10.1161/CIRCULATIONAHA.110.009035318149821444879Search in Google Scholar

24. AUNE D, SEN A, SCHLESINGER S, NORAT T, JANSZKY I, ROMUNDSTAD P et al. Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose–response meta-analysis of prospective studies. European Journal of Epidemiology. 2017;32(3):181-92. doi:10.1007/s10654-017-0232-4.10.1007/s10654-017-0232-4538069528194602Open DOISearch in Google Scholar

25. ASAD Z, ABBAS M, JAVED I, KORANTZOPOULOS P, STAVRAKIS S. Obesity is associated with incident atrial fibrillation independent of gender: A meta-analysis. Journal of Cardiovascular Electrophysiology. 2018;29(5):725-32. doi:doi:10.1111/jce.13458.10.1111/jce.1345829443438Open DOISearch in Google Scholar

26. WINKLE RA, MEAD RH, ENGEL G, KONG MH, FLEMING W, SALCEDO J et al. Impact of obesity on atrial fibrillation ablation: Patient characteristics, long-term outcomes, and complications. Heart rhythm. 2017;14(6):819-27. doi:10.1016/j.hrthm.2017.02.023.10.1016/j.hrthm.2017.02.02328232261Open DOISearch in Google Scholar

27. GALLAGHER C, HENDRIKS JML, ELLIOTT AD, WONG CX, RANGNEKAR G, MIDDELDORP ME et al. Alcohol and incident atrial fibrillation - A systematic review and meta-analysis. International journal of cardiology. 2017;246:46-52. doi:10.1016/j.ijcard.2017.05.133.10.1016/j.ijcard.2017.05.13328867013Open DOISearch in Google Scholar

28. PATHAK RK, MIDDELDORP ME, MEREDITH M, MEHTA AB, MAHAJAN R, WONG CX et al. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). Journal of the American College of Cardiology. 2015;65(20):2159-69. doi:10.1016/j.jacc.2015.03.002.10.1016/j.jacc.2015.03.00225792361Open DOISearch in Google Scholar

29. TSANG TS, BARNES ME, MIYASAKA Y, CHA SS, BAILEY KR, VERZOSA GC et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. European heart journal. 2008;29(18):2227-33.10.1093/eurheartj/ehn324273373918611964Search in Google Scholar

30. MUNGER TM, DONG Y-X, MASAKI M, OH JK, MANKAD SV, BORLAUG BA et al. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. Journal of the American College of Cardiology. 2012;60(9):851-60.10.1016/j.jacc.2012.03.04222726633Search in Google Scholar

31. GAETA M, BANDERA F, TASSINARI F, CAPASSO L, CARGNELUTTI M, PELISSERO G et al. Is epicardial fat depot associated with atrial fibrillation? A systematic review and meta-analysis. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(5):747-52.Search in Google Scholar

32. ANSARI MA, MOHEBATI M, POURSADEGH F, FOROUGHIAN M, SHAMLOO AS. Is echocardiographic epicardial fat thickness increased in patients with coronary artery disease? A systematic review and meta-analysis. Electronic physician. 2018;10(9):7249-58. doi:10.19082/7249.10.19082/7249Search in Google Scholar

33. LIP GYH, COCA A, KAHAN T, BORIANI G, MANOLIS AS, OLSEN MH et al. Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(6):891-911. doi:10.1093/europace/eux091.10.1093/europace/eux091Open DOISearch in Google Scholar

34. BRANDES A, SMIT MD, NGUYEN BO, RIENSTRA M, VAN GELDER IC. Risk Factor Management in Atrial Fibrillation. Arrhythmia & electrophysiology review. 2018;7(2):118-27. doi:10.15420/aer.2018.18.2.10.15420/aer.2018.18.2Search in Google Scholar

35. SCHNABEL RB, YIN X, GONA P, LARSON MG, BEISER AS, MCMANUS DD et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet (London, England). 2015;386(9989):154-62. doi:10.1016/s0140-6736(14)61774-8.10.1016/s0140-6736(14)61774-8Open DOISearch in Google Scholar

36. DE BECKER B, DE BORNE PHILIPPE V. Treatment of hypertension to prevent atrial fibrillation. Current pharmaceutical design. 2018. doi:10.2174/1381612825666181127100437.10.2174/138161282566618112710043730479208Open DOISearch in Google Scholar

37. PATHAK RK, MIDDELDORP ME, LAU DH, MEHTA AB, MAHAJAN R, TWOMEY D et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. Journal of the American College of Cardiology. 2014;64(21):2222-31. doi:10.1016/j.jacc.2014.09.028.10.1016/j.jacc.2014.09.02825456757Open DOISearch in Google Scholar

38. HEALEY JS, BARANCHUK A, CRYSTAL E, MORILLO CA, GARFINKLE M, YUSUF S et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. Journal of the American College of Cardiology. 2005;45(11):1832-9.10.1016/j.jacc.2004.11.07015936615Search in Google Scholar

39. DZESHKA MS, SHANTSILA A, SHANTSILA E, LIP GYH. Atrial Fibrillation and Hypertension. Hypertension (Dallas, Tex: 1979). 2017;70(5):854-61. doi:10.1161/hypertensionaha.117.08934.10.1161/hypertensionaha.117.0893428893897Open DOISearch in Google Scholar

40. STAERK L, SHERER JA, KO D, BENJAMIN EJ, HELM RH. Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circulation research. 2017;120(9):1501-17. doi:10.1161/circresaha.117.309732.10.1161/circresaha.117.309732Open DOISearch in Google Scholar

41. MEDI C, KALMAN JM, SPENCE SJ, TEH AW, LEE G, BADER I et al. Atrial electrical and structural changes associated with longstanding hypertension in humans: implications for the substrate for atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22(12):1317-24. doi:10.1111/j.1540-8167.2011.02125.x.10.1111/j.1540-8167.2011.02125.x21736657Open DOISearch in Google Scholar

42. TADIC M, CUSPIDI C. Type 2 diabetes mellitus and atrial fibrillation: From mechanisms to clinical practice. Archives of cardiovascular diseases. 2015;108(4):269-76. doi:10.1016/j.acvd.2015.01.009.10.1016/j.acvd.2015.01.00925858534Open DOISearch in Google Scholar

43. PALLISGAARD JL, SCHJERNING AM, LINDHARDT TB, PROCIDA K, HANSEN ML, TORP-PEDERSEN C et al. Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study. European journal of preventive cardiology. 2016;23(6):621-7. doi:10.1177/2047487315599892.10.1177/204748731559989226254188Open DOISearch in Google Scholar

44. HUXLEY RR, FILION KB, KONETY S, ALONSO A. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. The American journal of cardiology. 2011;108(1):56-62. doi:10.1016/j.amjcard. 2011.03.004.10.1016/j.amjcard.2011.03.004318149521529739Open DOISearch in Google Scholar

45. DUBLIN S, GLAZER NL, SMITH NL, PSATY BM, LUMLEY T, WIGGINS KL et al. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. Journal of general internal medicine. 2010;25(8):853-8. doi:10.1007/s11606-010-1340-y.10.1007/s11606-010-1340-y289658920405332Search in Google Scholar

46. AUNE D, FENG T, SCHLESINGER S, JANSZKY I, NORAT T, RIBOLI E. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. Journal of Diabetes and its Complications. 2018;32(5):501-11. doi:10.1016/j.jdiacomp.2018.02.004.10.1016/j.jdiacomp.2018.02.00429653902Open DOISearch in Google Scholar

47. YANG PS, KIM TH, UHM JS, PARK S, JOUNG B, LEE MH et al. High plasma level of soluble RAGE is independently associated with a low recurrence of atrial fibrillation after catheter ablation in diabetic patient. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2016;18(11):1711-8. doi:10.1093/europace/euv449.10.1093/europace/euv44926838688Search in Google Scholar

48. FATEMI O, YURIDITSKY E, TSIOUFIS C, TSACHRIS D, MORGAN T, BASILE J et al. Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). The American journal of cardiology. 2014;114(8):1217-22. doi:10.1016/j.amjcard.2014.07.045.10.1016/j.amjcard.2014.07.045429127825159234Search in Google Scholar

49. GOUDIS CA, KORANTZOPOULOS P, NTALAS IV, KALLERGIS EM, LIU T, KETIKOGLOU DG. Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies. International journal of cardiology. 2015;184:617-22. doi:10.1016/j.ijcard.2015.03.052.10.1016/j.ijcard.2015.03.05225770841Open DOISearch in Google Scholar

50. RIX TA, JOENSEN AM, RIAHI S, LUNDBYE-CHRISTENSEN S, TJONNELAND A, SCHMIDT EB et al. A U-shaped association between consumption of marine n-3 fatty acids and development of atrial fibrillation/atrial flutter-a Danish cohort study. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2014;16(11):1554-61. doi:10.1093/europace/euu019.10.1093/europace/euu01924574493Open DOISearch in Google Scholar

51. LARSSON SC, WOLK A. Fish, long-chain omega-3 polyunsaturated fatty acid intake and incidence of atrial fibrillation: A pooled analysis of two prospective studies. Clinical nutrition (Edinburgh, Scotland). 2017;36(2):537-41. doi:10.1016/j.clnu.2016.01.019.10.1016/j.clnu.2016.01.01926875446Open DOISearch in Google Scholar

52. MARTINEZ-GONZALEZ MA, TOLEDO E, AROS F, FIOL M, CORELLA D, SALAS-SALVADO J et al. Extravirgin olive oil consumption reduces risk of atrial fibrillation: the PREDIMED (Prevencion con Dieta Mediterranea) trial. Circulation. 2014;130(1):18-26. doi:10.1161/circulationaha.113.006921.10.1161/circulationaha.113.006921Open DOISearch in Google Scholar

53. MOSTOFSKY E, BERG JOHANSEN M, TJONNELAND A, CHAHAL HS, MITTLEMAN MA, OVERVAD K. Chocolate intake and risk of clinically apparent atrial fibrillation: the Danish Diet, Cancer, and Health Study. Heart (British Cardiac Society). 2017;103(15):1163-7. doi:10.1136/heartjnl-2016-310357.10.1136/heartjnl-2016-310357591269028536115Open DOISearch in Google Scholar

54. LARSSON SC, DRCA N, JENSEN-URSTAD M, WOLK A. Chocolate consumption and risk of atrial fibrillation: Two cohort studies and a meta-analysis. American heart journal. 2018;195:86-90. doi:10.1016/j.ahj.2017.09.013.10.1016/j.ahj.2017.09.01329224650Open DOISearch in Google Scholar

55. MOSTOFSKY E, JOHANSEN MB, LUNDBYE-CHRISTENSEN S, TJONNELAND A, MITTLEMAN MA, OVERVAD K. Risk of atrial fibrillation associated with coffee intake: Findings from the Danish Diet, Cancer, and Health study. European journal of preventive cardiology. 2016;23(9):922-30. doi:10.1177/2047487315624524.10.1177/2047487315624524602685426701875Open DOISearch in Google Scholar

56. DI CASTELNUOVO A, COSTANZO S, BONACCIO M, RAGO L, DE CURTIS A, PERSICHILLO M et al. Moderate alcohol consumption is associated with lower risk for heart failure but not atrial fibrillation. JACC Heart failure. 2017;5(11):837-44. doi:10.1016/j.jchf.2017.08.017.10.1016/j.jchf.2017.08.01729032141Open DOISearch in Google Scholar

57. DJOUSSE L, LEVY D, BENJAMIN EJ, BLEASE SJ, RUSS A, LARSON MG et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. The American journal of cardiology. 2004;93(6):710-3. doi:10.1016/j.amjcard.2003.12.004.10.1016/j.amjcard.2003.12.00415019874Open DOISearch in Google Scholar

58. LARSSON SC, DRCA N, WOLK A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. Journal of the American College of Cardiology. 2014;64(3):281-9. doi:10.1016/j.jacc.2014.03.048.10.1016/j.jacc.2014.03.04825034065Open DOISearch in Google Scholar

59. MESQUITA J, FERREIRA AM, CAVACO D, MOSCOSO COSTA F, CARMO P, MARQUES H et al. Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter ablation procedure – ATLAS score. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2018;20(Fi_3):f428-f35. doi:10.1093/europace/eux265.10.1093/europace/eux26529016770Open DOISearch in Google Scholar

60. BEBAROVA M, HORAKOVA Z, KULA R. Addictive drugs, arrhythmias, and cardiac inward rectifiers. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(3):346-55. doi:10.1093/europace/euw071.10.1093/europace/euw07127302393Open DOISearch in Google Scholar

61. ALBERTSEN IE, OVERVAD TF, LIP GY, LARSEN TB. Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemics. Curr Opin Cardiol. 2015;30(5):512-7. doi:10.1097/hco.0000000000000205.10.1097/hco.0000000000000205Open DOISearch in Google Scholar

62. WATANABE I. Smoking and risk of atrial fibrillation. Elsevier; 2018.10.1016/j.jjcc.2017.08.00128918306Search in Google Scholar

63. AUNE D, SCHLESINGER S, NORAT T, RIBOLI E. Tobacco smoking and the risk of atrial fibrillation: A systematic review and meta-analysis of prospective studies. European journal of preventive cardiology. 2018;25(13):1437-51. doi:10.1177/2047487318780435.10.1177/204748731878043529996680Open DOISearch in Google Scholar

64. O'NEAL WT, QURESHI WT, JUDD SE, MCCLURE LA, CUSHMAN M, HOWARD VJ et al. Environmental tobacco smoke and atrial fibrillation: The reasons for geographic and racial differences in stroke (REGARDS) study. Journal of occupational and environmental medicine. 2015;57(11):1154-8. doi:10.1097/jom.0000000000000565.10.1097/JOM.0000000000000565463601826539762Search in Google Scholar

65. DIXIT S, PLETCHER MJ, VITTINGHOFF E, IMBURGIA K, MAGUIRE C, WHITMAN IR et al. Secondhand smoke and atrial fibrillation: Data from the Health eHeart Study. Heart rhythm. 2016;13(1):3-9. doi:10.1016/j.hrthm.2015.08.004.10.1016/j.hrthm.2015.08.004469817826340844Open DOISearch in Google Scholar

66. SABZWARI SRA, GARG L, LAKKIREDDY D, DAY J. Ten lifestyle modification approaches to treat atrial fibrillation. Cureus. 2018;10(5):e2682. doi:10.7759/cureus.2682.10.7759/cureus.2682605952530050737Open DOISearch in Google Scholar

67. GOETTE A, LENDECKEL U, KUCHENBECKER A, BUKOWSKA A, PETERS B, KLEIN HU et al. Cigarette smoking induces atrial fibrosis in humans via nicotine. Heart (British Cardiac Society). 2007;93(9):1056-63. doi:10.1136/ hrt.2005.087171.10.1136/hrt.2005.087171195500317395670Open DOISearch in Google Scholar

68. WATANABE H, TANABE N, YAGIHARA N, WATANABE T, AIZAWA Y, KODAMA M. Association between lipid profile and risk of atrial fibrillation. Circulation journal: official journal of the Japanese Circulation Society. 2011;75(12):2767-74.10.1253/circj.CJ-11-078021914959Search in Google Scholar

69. RIENSTRA M, HOBBELT AH, ALINGS M, TIJSSEN JGP, SMIT MD, BRUGEMANN J et al. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial. Eur Heart J. 2018;39(32):2987-96. doi:10.1093/eurheartj/ehx739.10.1093/eurheartj/ehx73929401239Open DOISearch in Google Scholar

70. FANG WT, LI HJ, ZHANG H, JIANG S. The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. British journal of clinical pharmacology. 2012;74(5):744-56. doi:10.1111/j.1365-2125.2012.04258.x.10.1111/j.1365-2125.2012.04258.x349513922376147Open DOISearch in Google Scholar

71. VAN GELDER IC, HOBBELT AH, BRUGEMANN J, RIENSTRA M. Time to implement fitness and reduction of fatness in atrial fibrillation therapy. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(4):513-4. doi:10.1093/europace/euw287.10.1093/europace/euw28728431072Open DOISearch in Google Scholar

72. PROIETTI M, BORIANI G, LAROCHE C, DIEMBERGER I, POPESCU MI, RASMUSSEN LH et al. Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(4):535-43. doi:10.1093/europace/euw150.10.1093/europace/euw15028431068Open DOISearch in Google Scholar

73. ELLIOTT AD, MAATMAN B, EMERY MS, SANDERS P. The role of exercise in atrial fibrillation prevention and promotion: Finding optimal ranges for health. Heart rhythm. 2017;14(11):1713-20. doi:10.1016/j.hrthm.2017.07.001.10.1016/j.hrthm.2017.07.00128694186Open DOISearch in Google Scholar

74. FLANNERY MD, KALMAN JM, SANDERS P, LA GERCHE A. State of the art review: atrial fibrillation in athletes. Heart, lung & circulation. 2017;26(9):983-9. doi:10.1016/j.hlc.2017.05.132.10.1016/j.hlc.2017.05.13228606607Open DOISearch in Google Scholar

75. DRCA N, WOLK A, JENSEN-URSTAD M, LARSSON SC. Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women. Heart (British Cardiac Society). 2015;101(20):1627-30. doi:10.1136/heartjnl-2014-307145.10.1136/heartjnl-2014-30714526019224Open DOISearch in Google Scholar

76. MITTAL S. Physical Activity and Incidence of Atrial Fibrillation in Older Adults: The Cardiovascular Health Study. Journal of atrial fibrillation. 2008;1(3):132. doi:10.4022/jafib.132.10.4022/jafib.132495637728496592Open DOISearch in Google Scholar

77. YANG Y, HAN X, CHEN Y, GAO L, YIN X, LI H et al. Association between modifiable lifestyle and the prevalence of atrial fibrillation in a Chinese population: Based on the cardiovascular health score. Clinical cardiology. 2017;40(11):1061-7. doi:10.1002/clc.22771.10.1002/clc.22771649034428833291Open DOISearch in Google Scholar

78. PARK J, KYOUNG AK. 136-75: Gender difference of life style patterns including smoking, alcohol, and physical activity related to new onset atrial fibrillation: A nationwide cohort study in Korea. EP Europace. 2016;18(suppl_1):i109-i. doi:10.1093/europace/18.suppl_1.i109a.10.1093/europace/18.suppl_1.i109aOpen DOISearch in Google Scholar

79. RICCI C, GERVASI F, GAETA M, SMUTS CM, SCHUTTE AE, LEITZMANN MF. Physical activity volume in relation to risk of atrial fibrillation. A non-linear meta-regression analysis. European journal of preventive cardiology. 2018;25(8):857-66. doi:10.1177/2047487318768026.10.1177/204748731876802629591534Search in Google Scholar

80. SEPEHRI SHAMLOO A, ARYA A, DAGRES N, HINDRICKS G. Exercise and atrial fibrillation: some good news and some bad news. GMJ. 2018;7:e1401. doi:10.22086/gmj.v0i0.1401.Search in Google Scholar

81. VIDAL A, AGORRODY V, ABREU R, VIANA P, DODERA A, VIDAL L. Vagal third-degree atrioventricular block in a highly trained endurance athlete. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(11):1863. doi:10.1093/europace/eux045.10.1093/europace/eux04528430941Open DOISearch in Google Scholar

82. LINZ D, HOHL M, VOLLMAR J, UKENA C, MAHFOUD F, BOHM M. Atrial fibrillation and gastroesophageal reflux disease: the cardiogastric interaction. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2017;19(1):16-20. doi:10.1093/europace/euw092.10.1093/europace/euw09227247004Open DOISearch in Google Scholar

83. EL-BATTRAWY I, LANG S, ZHOU X, BORGGREFE M, AKIN I. The link between atrial fibrillation and hereditary channelopathies. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2018;20(11):1872. doi:10.1093/europace/euy109.10.1093/europace/euy10929878098Open DOISearch in Google Scholar

84. SENTURK T, XU H, PUPPALA K, KRISHNAN B, SAKAGUCHI S, CHEN LY et al. Cardiac pauses in competitive athletes: a systematic review examining the basis of current practice recommendations. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2016;18(12):1873-9. doi:10.1093/europace/euv373.10.1093/europace/euv373529119026590379Open DOISearch in Google Scholar

85. SEPEHRI SHAMLOO A, ARYA A, DAGRES N, HINDRICKS G. Sleep disorders and atrial fibrillation: current situation and future directions. GMJ. 2018;7:e1416. doi:10.22086/gmj.v0i0.1416.Search in Google Scholar

86. ZHAO E, CHEN S, DU Y, ZHANG Y. Association between sleep apnea hypopnea syndrome and the risk of atrial fibrillation: A meta-analysis of cohort study. BioMed research international. 2018;2018:5215868. doi:10.1155/2018/5215868.10.1155/2018/5215868582283029581977Open DOISearch in Google Scholar

87. YOUSSEF I, KAMRAN H, YACOUB M, PATEL N, GOULBOURNE C, KUMAR S et al. Obstructive sleep apnea as a risk factor for atrial fibrillation: A meta-analysis. Journal of sleep disorders & therapy. 2018;7(1). doi:10.4172/2167-0277.1000282.10.4172/2167-0277.1000282589840129657903Open DOISearch in Google Scholar

88. MAY AM, BLACKWELL T, STONE PH, STONE KL, CAWTHON PM, SAUER WH et al. Central Sleep-disordered Breathing Predicts Incident Atrial Fibrillation in Older Men. American journal of respiratory and critical care medicine. 2016;193(7):783-91. doi:10.1164/rccm.201508-1523OC.10.1164/rccm.201508-1523OC482493226595380Open DOISearch in Google Scholar

89. kwon y, gharib sa, biggs ml, jacobs DR, Jr., ALONSO A, DUPREZ D et al. Association of sleep characteristics with atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis. Thorax. 2015;70(9):873-9. doi:10.1136/thoraxjnl-2014-206655.10.1136/thoraxjnl-2014-206655549546325986436Open DOISearch in Google Scholar

90. GHAZI L, BENNETT A, PETROV ME, HOWARD VJ, SAFFORD MM, SOLIMAN EZ et al. Race, sex, age, and regional differences in the association of obstructive sleep apnea with atrial fibrillation: reasons for geographic and racial differences in stroke study. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. 2018;14(9):1485-93. doi:10.5664/jcsm.7320.10.5664/jcsm.7320613425430176963Open DOISearch in Google Scholar

91. DENG F, RAZA A, GUO J. Treating obstructive sleep apnea with continuous positive airway pressure reduces risk of recurrent atrial fibrillation after catheter ablation: a meta-analysis. Sleep medicine. 2018;46:5-11. doi:10.1016/j.sleep.2018.02.013.10.1016/j.sleep.2018.02.01329773211Open DOISearch in Google Scholar

92. LAU DH, NATTEL S, KALMAN JM, SANDERS P. Modifiable risk factors and atrial fibrillation. Circulation. 2017;136(6):583-96. doi:10.1161/circulationaha.116.023163.10.1161/circulationaha.116.02316328784826Open DOISearch in Google Scholar

93. GAO M, ZHANG L, SCHERLAG BJ, HUANG B, STAVRAKIS S, HOU YM et al. Low-level vagosympathetic trunk stimulation inhibits atrial fibrillation in a rabbit model of obstructive sleep apnea. Heart rhythm. 2015;12(4):818-24. doi:10.1016/j.hrthm.2014.12.024.10.1016/j.hrthm.2014.12.02425533582Open DOISearch in Google Scholar